FR2271210A1 - Antileprotic compsns - contg 4,4'-bis(2,4-dioxy-6-methylpyrimidinyl-5-sulphonamido) diphenyl sulphone - Google Patents
Antileprotic compsns - contg 4,4'-bis(2,4-dioxy-6-methylpyrimidinyl-5-sulphonamido) diphenyl sulphoneInfo
- Publication number
- FR2271210A1 FR2271210A1 FR7416638A FR7416638A FR2271210A1 FR 2271210 A1 FR2271210 A1 FR 2271210A1 FR 7416638 A FR7416638 A FR 7416638A FR 7416638 A FR7416638 A FR 7416638A FR 2271210 A1 FR2271210 A1 FR 2271210A1
- Authority
- FR
- France
- Prior art keywords
- sulphonamido
- dioxy
- bis
- treatment
- leprosy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7416638A FR2271210A1 (en) | 1974-05-14 | 1974-05-14 | Antileprotic compsns - contg 4,4'-bis(2,4-dioxy-6-methylpyrimidinyl-5-sulphonamido) diphenyl sulphone |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR7416638A FR2271210A1 (en) | 1974-05-14 | 1974-05-14 | Antileprotic compsns - contg 4,4'-bis(2,4-dioxy-6-methylpyrimidinyl-5-sulphonamido) diphenyl sulphone |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2271210A1 true FR2271210A1 (en) | 1975-12-12 |
FR2271210B1 FR2271210B1 (hr) | 1978-01-27 |
Family
ID=9138805
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR7416638A Granted FR2271210A1 (en) | 1974-05-14 | 1974-05-14 | Antileprotic compsns - contg 4,4'-bis(2,4-dioxy-6-methylpyrimidinyl-5-sulphonamido) diphenyl sulphone |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2271210A1 (hr) |
-
1974
- 1974-05-14 FR FR7416638A patent/FR2271210A1/fr active Granted
Also Published As
Publication number | Publication date |
---|---|
FR2271210B1 (hr) | 1978-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stoelting | The use of a new intravenous oxygen barbiturate 25398 for intravenous anesthesia (a preliminary report) | |
US2877253A (en) | Therapeutic iron complex | |
Hahn et al. | Radioactive iron and its metabolism in anemia | |
McEwen et al. | The effect of cortisone and ACTH on rheumatic fever | |
Zipser et al. | Hypocalcemic tetany due to sodium phosphate ingestion in acute renal failure | |
Lehman | Further Studies on the Acute Toxicity of Mercurial Diuretics. | |
Bowman | Clinical evaluation of dextran as a plasma volume expander | |
US2761807A (en) | Glycocyamine and methylating agent in vivo creatine producing composition | |
Bessen et al. | Improvement of cardiac conduction after hyperventilation in tricyclic antidepressant overdose | |
Lewis | Iron and Copper in the Treatment of Anemia in Children | |
Marley et al. | Cardiac failure with reserpine | |
Silver et al. | Chronic arsenic poisoning following use of an asthma remedy | |
FR2271210A1 (en) | Antileprotic compsns - contg 4,4'-bis(2,4-dioxy-6-methylpyrimidinyl-5-sulphonamido) diphenyl sulphone | |
FR2248026A1 (en) | Antileprotic compsns - contg 4,4'-bis(2,4-dioxy-6-methylpyrimidinyl-5-sulphonamido) diphenyl sulphone | |
US3039927A (en) | Pharmaceutical composition comprising aspirin and sorbitol | |
KAUFMAN | Immediate fatalities after intravenous mercurial diuretics | |
Stallard et al. | Muscarinic poisoning from medications and mushrooms: A puzzling symptom complex | |
Thurston et al. | Lung changes associated with phenylbutazone treatment. | |
JPS5551019A (en) | Drug containing alllee or 133zz7*88dehydroo retine acid and manufacture thereof | |
Chiang et al. | THE EFFECT OF SOMATOSTATIN ON PLATELET AGGREGATION1 | |
Chouinard et al. | Alpha methyldopa-chlorpromazine interaction in schizophrenic patients. | |
Worlock | Barbiturate poisoning treated with amiphenazole and bemegride | |
MacKenzie et al. | Fetal death in utero managed with vaginal prostaglandin E2 gel. | |
Schilling et al. | A new approach to fluid therapy of the severely burned patient: the use of urea as an electrolyte substitute | |
Heinonen et al. | Orphenadrine poisoning: A case report supplemented with animal experiments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |